Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
This regulatory distinction creates substantial patient safety concerns
This includes utilizing powerful medications like Wegovy and Zepbound, which are leading the charge in not just treating existing conditions, but in preventing future health crises
Federal Efforts to Regulate PBMs In February 2026, Congress enacted legislation that will address some PBM business practices, including: Delinking PBM compensation from the price of a drug, or any rebates or discounts that they negotiate for drug plans under Medicare Part D and instead basing compensation on a bona fide service fee, which will be a flat dollar amount that reflects the fair market value of services provided by PBMs, beginning January 1, 2028
US$ 23.45
US$ 23.14
US$ 27.95
US$ 22.71
US$ 29.18
US$ 23.78
US$ 29.07
US$ 21.17
US$ 29.62
US$ 21.25
